2017
|
Sign up to set email alerts
Genetic diagnosis of Mendelian disorders via RNA sequencing
Abstract: Across a variety of Mendelian disorders, ∼50–75% of patients do not receive a genetic diagnosis by exome sequencing indicating disease-causing variants in non-coding regions. Although genome sequencing in principle reveals all genetic variants, their sizeable number and poorer annotation make prioritization challenging. Here, we demonstrate the power of transcriptome sequencing to molecularly diagnose 10% (5 of 48) of mitochondriopathy patients and identify candidate genes for the remainder. We find a median o… Show more
View preprint versions
Search citation statements
Order By: Relevance
Paper Sections
Select...
515
103
80
39
Citation Types
17
605
0
2
Year Published
Range
2000
20002026
2026Publication Types
Select...
481
86
83
31
Relationship
90
591
Authors
Journals
Cited by 680 publications
(624 citation statements)
References 89 publications
17
605
0
2
Order By: Relevance
Smart CitationsHow the paper below cites the one you are viewing
“…This emphasized the value of complementary analysis strategies in large RNA-seq datasets to characterize different effects of LoF variants on expression. In line with earlier findings 11, 14 , for most pre-identified bi-allelic and mono-allelic/hemizygous missense variants, we observed no significant RNA outlier events (8/9, 88.9%; Fig.4A/B ; Suppl.Tab.1 ). However, when present, as seen in patient R072 ( Fig.4C ; Suppl.Tab.1 ), RNA-seq prompted reconsideration of the significance of a predicted missense variant.…”
Section: Results
supporting
confidence: 92%
“…We assessed the capacity of our RNA-seq analysis pipeline to resolve RNA defects associated with pre-identified variants. We replicated previous observations 11, 14 that many LoF variants (bi- and mono-allelic, 10/15, 66.7%) caused significant AE detectable by OUTRIDER, suggesting that RNA-seq and outlier analysis can successfully be used for uncovering dystonia-relevant underexpression and pathogenic mechanisms such as haploinsufficiency (e.g., for VPS16 -related dystonia, 3/3 cases; Fig.4A/B ; Suppl.Tab.1 ). While our stringent significance cutoff did not retain AE events for 4 cases with heterozygous LoF variants, additional sample rank-based evaluation 3, 32 constituted a useful complementary strategy.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…This emphasized the value of complementary analysis strategies in large RNA-seq datasets to characterize different effects of LoF variants on expression. In line with earlier findings 11, 14 , for most pre-identified bi-allelic and mono-allelic/hemizygous missense variants, we observed no significant RNA outlier events (8/9, 88.9%; Fig.4A/B ; Suppl.Tab.1 ). However, when present, as seen in patient R072 ( Fig.4C ; Suppl.Tab.1 ), RNA-seq prompted reconsideration of the significance of a predicted missense variant.…”
Section: Results
supporting
confidence: 92%
“…We assessed the capacity of our RNA-seq analysis pipeline to resolve RNA defects associated with pre-identified variants. We replicated previous observations 11, 14 that many LoF variants (bi- and mono-allelic, 10/15, 66.7%) caused significant AE detectable by OUTRIDER, suggesting that RNA-seq and outlier analysis can successfully be used for uncovering dystonia-relevant underexpression and pathogenic mechanisms such as haploinsufficiency (e.g., for VPS16 -related dystonia, 3/3 cases; Fig.4A/B ; Suppl.Tab.1 ). While our stringent significance cutoff did not retain AE events for 4 cases with heterozygous LoF variants, additional sample rank-based evaluation 3, 32 constituted a useful complementary strategy.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…This emphasized the value of complementary analysis strategies in large RNA-seq datasets to characterize different effects of LoF variants on expression. In line with earlier findings, 7,10 for most pre-identified bi-allelic and mono-allelic/ hemizygous missense variants, we observed no significant RNA outlier events (8/9, 88.9%; see Fig. 4A, B and Supplementary Table S1).…”
Section: Results
supporting
confidence: 92%
“…We assessed the capacity of our RNA-seq analysis pipeline to resolve RNA defects associated with preidentified variants. We replicated previous observations 7,10 that many LoF variants (bi-and mono-allelic, 10/15, 66.7%) caused significant AE detectable by OUTRIDER, suggesting that RNA-seq and outlier analysis can successfully be used for uncovering dystoniarelevant underexpression and pathogenic mechanisms, such as haploinsufficiency (eg, for VPS16-related dystonia, 3/3 cases; see Fig 4A,B, and Supplementary Table S1). Whereas our stringent significance cutoff did not retain AE events for 4 cases with heterozygous LoF variants, additional sample rank-based evaluation 3,32 constituted a useful complementary strategy.…”
Section: Discussion
supporting
confidence: 88%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Clinical trials also found that in patients with mitochondrial disease caused by TIMMDC1 deletion, the complex I was deficiency in muscle and the levels of complex I subunits in fibroblasts were globally decreased. However, re-expression of TIMMDC1 in these cells increased the levels of complex I subunits, which is consistent with the described function of TIMMDC1 as a respiratory chain complex I assembly factor 21 . In order to explore the role of TIMMDC1 in gastric cancer cells, we knockdown TIMMDC1 by small interfering (si) RNAs in SGC-7901 cells and BGC-823 cells.…”
Section: Discussion
supporting
confidence: 88%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…This emphasized the value of complementary analysis strategies in large RNA-seq datasets to characterize different effects of LoF variants on expression. In line with earlier findings 11, 14 , for most pre-identified bi-allelic and mono-allelic/hemizygous missense variants, we observed no significant RNA outlier events (8/9, 88.9%; Fig.4A/B ; Suppl.Tab.1 ). However, when present, as seen in patient R072 ( Fig.4C ; Suppl.Tab.1 ), RNA-seq prompted reconsideration of the significance of a predicted missense variant.…”
Section: Results
supporting
confidence: 92%
“…We assessed the capacity of our RNA-seq analysis pipeline to resolve RNA defects associated with pre-identified variants. We replicated previous observations 11, 14 that many LoF variants (bi- and mono-allelic, 10/15, 66.7%) caused significant AE detectable by OUTRIDER, suggesting that RNA-seq and outlier analysis can successfully be used for uncovering dystonia-relevant underexpression and pathogenic mechanisms such as haploinsufficiency (e.g., for VPS16 -related dystonia, 3/3 cases; Fig.4A/B ; Suppl.Tab.1 ). While our stringent significance cutoff did not retain AE events for 4 cases with heterozygous LoF variants, additional sample rank-based evaluation 3, 32 constituted a useful complementary strategy.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…This emphasized the value of complementary analysis strategies in large RNA-seq datasets to characterize different effects of LoF variants on expression. In line with earlier findings, 7,10 for most pre-identified bi-allelic and mono-allelic/ hemizygous missense variants, we observed no significant RNA outlier events (8/9, 88.9%; see Fig. 4A, B and Supplementary Table S1).…”
Section: Results
supporting
confidence: 92%
“…We assessed the capacity of our RNA-seq analysis pipeline to resolve RNA defects associated with preidentified variants. We replicated previous observations 7,10 that many LoF variants (bi-and mono-allelic, 10/15, 66.7%) caused significant AE detectable by OUTRIDER, suggesting that RNA-seq and outlier analysis can successfully be used for uncovering dystoniarelevant underexpression and pathogenic mechanisms, such as haploinsufficiency (eg, for VPS16-related dystonia, 3/3 cases; see Fig 4A,B, and Supplementary Table S1). Whereas our stringent significance cutoff did not retain AE events for 4 cases with heterozygous LoF variants, additional sample rank-based evaluation 3,32 constituted a useful complementary strategy.…”
Section: Discussion
supporting
confidence: 88%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Clinical trials also found that in patients with mitochondrial disease caused by TIMMDC1 deletion, the complex I was deficiency in muscle and the levels of complex I subunits in fibroblasts were globally decreased. However, re-expression of TIMMDC1 in these cells increased the levels of complex I subunits, which is consistent with the described function of TIMMDC1 as a respiratory chain complex I assembly factor 21 . In order to explore the role of TIMMDC1 in gastric cancer cells, we knockdown TIMMDC1 by small interfering (si) RNAs in SGC-7901 cells and BGC-823 cells.…”
Section: Discussion
supporting
confidence: 88%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…This emphasized the value of complementary analysis strategies in large RNA-seq datasets to characterize different effects of LoF variants on expression. In line with earlier findings 11, 14 , for most pre-identified bi-allelic and mono-allelic/hemizygous missense variants, we observed no significant RNA outlier events (8/9, 88.9%; Fig.4A/B ; Suppl.Tab.1 ). However, when present, as seen in patient R072 ( Fig.4C ; Suppl.Tab.1 ), RNA-seq prompted reconsideration of the significance of a predicted missense variant.…”
Section: Results
supporting
confidence: 92%
“…We assessed the capacity of our RNA-seq analysis pipeline to resolve RNA defects associated with pre-identified variants. We replicated previous observations 11, 14 that many LoF variants (bi- and mono-allelic, 10/15, 66.7%) caused significant AE detectable by OUTRIDER, suggesting that RNA-seq and outlier analysis can successfully be used for uncovering dystonia-relevant underexpression and pathogenic mechanisms such as haploinsufficiency (e.g., for VPS16 -related dystonia, 3/3 cases; Fig.4A/B ; Suppl.Tab.1 ). While our stringent significance cutoff did not retain AE events for 4 cases with heterozygous LoF variants, additional sample rank-based evaluation 3, 32 constituted a useful complementary strategy.…”
Section: Discussion
supporting
confidence: 90%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…This emphasized the value of complementary analysis strategies in large RNA-seq datasets to characterize different effects of LoF variants on expression. In line with earlier findings, 7,10 for most pre-identified bi-allelic and mono-allelic/ hemizygous missense variants, we observed no significant RNA outlier events (8/9, 88.9%; see Fig. 4A, B and Supplementary Table S1).…”
Section: Results
supporting
confidence: 92%
“…We assessed the capacity of our RNA-seq analysis pipeline to resolve RNA defects associated with preidentified variants. We replicated previous observations 7,10 that many LoF variants (bi-and mono-allelic, 10/15, 66.7%) caused significant AE detectable by OUTRIDER, suggesting that RNA-seq and outlier analysis can successfully be used for uncovering dystoniarelevant underexpression and pathogenic mechanisms, such as haploinsufficiency (eg, for VPS16-related dystonia, 3/3 cases; see Fig 4A,B, and Supplementary Table S1). Whereas our stringent significance cutoff did not retain AE events for 4 cases with heterozygous LoF variants, additional sample rank-based evaluation 3,32 constituted a useful complementary strategy.…”
Section: Discussion
supporting
confidence: 88%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…Clinical trials also found that in patients with mitochondrial disease caused by TIMMDC1 deletion, the complex I was deficiency in muscle and the levels of complex I subunits in fibroblasts were globally decreased. However, re-expression of TIMMDC1 in these cells increased the levels of complex I subunits, which is consistent with the described function of TIMMDC1 as a respiratory chain complex I assembly factor 21 . In order to explore the role of TIMMDC1 in gastric cancer cells, we knockdown TIMMDC1 by small interfering (si) RNAs in SGC-7901 cells and BGC-823 cells.…”
Section: Discussion
supporting
confidence: 88%
Abstract